NDUFV1 attenuates renal ischemia–reperfusion injury by improving mitochondrial homeostasis
Journal of Cellular and Molecular Medicine · 2023-05 · 27 (10) · 1341-1352
DOI: 10.1111/jcmm.17735 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 07.04.2023. Verfasst von Lu Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Affiliated Hospital of Nantong University, 20 Xisi Road, Nantong, Jiangsu, 226001, China. Hauptthemen laut MEDLINE: Acute Kidney Injury, Reperfusion Injury. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Impaired mitochondrial function and dysregulated energy metabolism have been shown to be involved in the pathological progression of kidney diseases such as acute kidney injury (AKI) and diabetic nephropathy. Hence, improving mitochondrial function is a promising strategy for treating renal dysfunction. NADH: ubiquinone oxidoreductase core subunit V1 (NDUFV1) is an important subunit of mitochondrial complex I. In the present study, we found that NDUFV1 was reduced in kidneys of renal ischemia/reperfusion (I/R) mice. Meanwhile, renal I/R induced kidney dysfunction as evidenced by increases in BUN and serum creatinine, severe injury of proximal renal tubules, oxidative stress, and cell apoptosis. All these detrimental outcomes were attenuated by increased expression of NDUFV1 in kidneys. Moreover, knockdown of Ndufv1 aggravated cell insults induced by H 2 O 2 in TCMK‐1 cells, which further confirmed the renoprotective roles of NDUFV1. Mechanistically, NDUFV1 improved the integrity and function of mitochondria, leading to reduced oxidative stress and cell apoptosis. Overall, our data indicate that NDUFV1 has an ability to maintain mitochondrial homeostasis in AKI, suggesting therapies by targeting mitochondria are useful approaches for dealing with mitochondrial dysfunction associated renal diseases such as AKI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Affiliated Hospital of Nantong University, 20 Xisi Road, Nantong, Jiangsu, 226001, China.
- Medical School of Nantong University, Nantong, 226001, China.
ORCID-Profile: Xinzhong Huang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, L., Zhang, L., Cao, Y., Chen, X., Gong, H., Ma, Y., Gui, Y., Xiang, T., Liu, J., & Huang, X. (2023). NDUFV1 attenuates renal ischemia–reperfusion injury by improving mitochondrial homeostasis. Journal of Cellular and Molecular Medicine, 27(10), 1341-1352. https://doi.org/10.1111/jcmm.17735
Vancouver
Li L, Zhang L, Cao Y, Chen X, Gong H, Ma Y, et al. NDUFV1 attenuates renal ischemia–reperfusion injury by improving mitochondrial homeostasis. Journal of Cellular and Molecular Medicine. 2023;27(10):1341-1352. doi:10.1111/jcmm.17735
BibTeX
@article{Li2023,
author = {Li, Lu and Zhang, Lingling and Cao, Yingjie and Chen, Xu and Gong, Haifeng and Ma, Yidan and Gui, Yuanyuan and Xiang, Tianya and Liu, Jianxing and Huang, Xinzhong},
title = {NDUFV1 attenuates renal ischemia–reperfusion injury by improving mitochondrial homeostasis},
journal = {Journal of Cellular and Molecular Medicine},
year = {2023},
volume = {27},
number = {10},
pages = {1341--1352},
doi = {10.1111/jcmm.17735}
}
EUVIMED